Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles.

Area of Science:

• Nanomedicine
• Materials Science
• Biomedical Engineering

Background:

• Inorganic nanoparticles offer potential for detection, diagnosis, and therapy.
• Nanoparticle surface properties, like charge, are crucial for in vivo behavior.
• Limited understanding exists on how surface chemistry affects nanoparticle pharmacokinetics, tumor uptake, and biodistribution.

Purpose of the Study:

• To investigate the influence of nanoparticle surface charge on pharmacokinetic properties.
• To evaluate the impact of surface charge on tumor uptake and biodistribution in vivo.
• To compare the performance of neutral, zwitterionic, negative, and positive nanoparticles.

Main Methods:

• Utilized a series of structurally homologous nanoparticles with varying surface charges (neutral, zwitterionic, negative, positive).
• Administered nanoparticles intravenously (i.v.) and intraperitoneally (i.p.) into normal and athymic mice.
• Assessed nanoparticle circulation time, tumor uptake, and biodistribution.

Main Results:

• Neutral (TEGOH) and zwitterionic (Tzwit) nanoparticles exhibited prolonged circulation times after both i.v. and i.p. administration.
• Negatively (TCOOH) and positively (TTMA) charged nanoparticles had significantly shorter half-lives.
• Pharmacological behavior correlated with tumor uptake, with neutral and zwitterionic nanoparticles showing enhanced passive targeting to tumors.

Conclusions:

• Nanoparticle surface charge is a critical determinant of in vivo pharmacokinetics and biodistribution.
• Neutral and zwitterionic surface chemistries are advantageous for achieving longer circulation times and improved tumor accumulation.
• These findings provide valuable insights for designing nanoparticles with optimized properties for biomedical applications.